NCT05541523 is a NA clinical trial of cognitive behavioural therapy in End-of-life, sponsored by Huichao Zhang.

Who is sponsoring NCT05541523?

NCT05541523 is sponsored by Huichao Zhang.

What drugs are being tested in NCT05541523?

Interventions in NCT05541523: cognitive behavioural therapy, mindfulness-based therapy.

What condition does NCT05541523 study?

NCT05541523 studies End-of-life, Depression, Anxiety.

Is NCT05541523 still recruiting?

NCT05541523 is currently status unknown. Last updated 15 September 2022.

Last reviewed 2022-09-15 · How we verify

NCT05541523

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improve Mental Health and Emotional Labor Among Nurses Who Care the End-of-life Patients

Status unknown NA Last updated 15 September 2022

What this trial tests

NA trial testing cognitive behavioural therapy in End-of-life in 100 participants. Status unknown.

Timeline

1 May 2022

Primary endpoint
30 December 2022

1 January 2023

Quick facts

Lead sponsor	Huichao Zhang
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	100
Start date	1 May 2022
Primary completion	30 December 2022
Estimated completion	1 January 2023
Sites	2 locations across China

Drugs / interventions tested

cognitive behavioural therapy
mindfulness-based therapy

Conditions studied

End-of-life — all drugs for End-of-life →
Depression, Anxiety — all drugs for Depression, Anxiety →

Sponsor

Huichao Zhang

Who can join

Adults 18 to 60, any sex, with End-of-life or Depression, Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

CBT: cognitive behavioural therapy MBT: mindfulness-based therapy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of cognitive behavioural therapy

Trials testing the same drug.

NCT05290311 — Long-Term Effects of CBT on Quality of Life in Adults With ADHD · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05541523 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Huichao Zhang
Last refreshed: 15 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05541523.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing